Amvis Holdings.Inc. (7071) AI Stock Analysis

• Market Cap: ¥58.69B
• Dividend Yield: 0.67%
• Average Volume (3M): 588.88K
• Price to Earnings (P/E): 16.3
• Beta (1Y): 1.00
• Revenue Growth: 15.60%
• EPS Growth: -51.75%
• Country: JP
• Employees: 4,046
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 5.89
• Shares Outstanding: 98,313,600
• 10 Day Avg. Volume: 603,990
• 30 Day Avg. Volume: 588,880
• PEG Ratio: 1.44
• Price to Book (P/B): 5.69
• Price to Sales (P/S): 4.45
• P/FCF Ratio: -22.16
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥665.00
• Price Target Upside: 11.39% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 71 Outperform
• Price Target: ¥665.00 ▲(11.39% Upside)

Amvis Holdings Inc. demonstrates strong financial performance with significant revenue growth and solid profitability margins, which are the most significant factors in its overall score. The valuation is attractive with a low P/E ratio, suggesting potential undervaluation. However, technical analysis indicates mixed signals, and cash flow management remains a concern, which slightly offsets the positive aspects.

Amvis Holdings.Inc. Business Overview & Revenue Model

Company Description

Amvis Holdings Inc. (7071) is a Japanese company primarily engaged in the healthcare sector. The company specializes in providing hospice and home care services, focusing on end-of-life care for patients with terminal illnesses. Its core services aim to enhance the quality of life for patients and support families through comprehensive care plans managed by professional medical staff.

How the Company Makes Money

Amvis Holdings Inc. generates revenue through its hospice and home care services. The company primarily earns money by offering customized care programs tailored to the needs of patients requiring end-of-life care. These services are often covered by health insurance plans, government subsidies, or out-of-pocket payments from patients and their families. Additionally, the company may form partnerships with healthcare providers and institutions to expand its service offerings and reach more clients, further driving its revenue growth. Key factors contributing to its earnings include the increasing demand for specialized healthcare services due to an aging population and the rising awareness of the benefits of hospice care.

Amvis Holdings.Inc. Financial Statement Overview

Summary

Amvis Holdings Inc. shows strong revenue growth and profitability with a 32.8% increase in revenue and solid margins. However, the balance sheet reveals rising debt levels, and cash flow management is a concern with zero free cash flow reported, indicating a need for strategic improvements.

Income Statement

Amvis Holdings Inc. demonstrates robust financial performance with steady revenue growth, as indicated by a significant TTM revenue of 44.7 billion JPY compared to 31.9 billion JPY in the previous annual period, marking a growth rate of approximately 32.8%. The gross profit margin remains strong at 38.3% in TTM, reflecting effective cost management. The net profit margin is healthy at 15.6% in TTM, though there has been a slight decline from previous periods, suggesting some pressure on net income. EBIT and EBITDA margins are also solid at 22.3% and 26.5% respectively, showcasing operational efficiency.

Balance Sheet

The balance sheet of Amvis Holdings Inc. indicates a strong equity position with a debt-to-equity ratio of 0.99 in TTM, which is manageable, though it has increased compared to previous years. The company's equity ratio stands at 45.9%, reflecting a balanced capital structure. Return on equity is impressive at 20.6% in TTM, indicating effective use of shareholder funds. However, the increased total debt level may pose potential risks if not managed carefully.

Cash Flow

Cash flow analysis reveals challenges, as the company reports a zero free cash flow in TTM, indicating issues in cash generation after investments. The operating cash flow to net income ratio is unavailable due to missing data, which makes it difficult to assess cash flow efficiency. Historical data shows a negative trend in free cash flow, highlighting the need for improved cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	46.70B	42.48B	31.98B	23.07B	15.33B	9.17B
Gross Profit	16.71B	17.06B	13.27B	9.69B	6.30B	3.75B
EBITDA	11.56B	12.76B	10.39B	7.10B	4.48B	2.17B
Net Income	6.33B	7.44B	6.31B	4.28B	2.63B	1.24B
Balance Sheet
Total Assets	82.68B	71.80B	55.56B	41.77B	31.92B	16.52B
Cash, Cash Equivalents and Short-Term Investments	11.81B	8.87B	12.13B	11.34B	11.19B	3.33B
Total Debt	40.32B	31.75B	23.05B	17.43B	12.75B	9.55B
Total Liabilities	47.52B	38.59B	29.04B	21.31B	15.58B	11.27B
Stockholders Equity	35.16B	33.21B	26.52B	20.46B	16.34B	5.25B
Cash Flow
Free Cash Flow	0.00	-8.52B	-3.06B	-2.73B	-2.79B	-3.78B
Operating Cash Flow	0.00	7.48B	6.80B	4.42B	2.58B	1.17B
Investing Cash Flow	0.00	-16.83B	-10.31B	-7.75B	-5.78B	-5.30B
Financing Cash Flow	0.00	6.08B	4.30B	3.49B	11.05B	7.02B

Amvis Holdings.Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 597.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Negative. The current price of 597 is below the 20-day moving average (MA) of 614.24, below the 50-day MA of 617.39, and above the 200-day MA of 561.54, indicating a neutral trend. The MACD of 1.57 indicates Positive momentum. The RSI at 44.91 is Neutral, neither overbought nor oversold. The STOCH value of 21.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7071.

Amvis Holdings.Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2374	79 Outperform	¥20.85B	11.91	―	3.60%	4.31%	-9.01%
6099	76 Outperform	€48.37B	20.18	20.78%	1.63%	15.78%	-7.51%
6197	74 Outperform	¥47.47B	10.86	―	4.19%	1.43%	―
7071	71 Outperform	¥58.69B	16.30	―	0.67%	15.60%	-51.75%
9158	67 Neutral	¥33.42B	14.08	―	―	37.50%	-22.93%
6062	63 Neutral	¥35.48B	12.10	―	3.13%	-2.42%	-31.36%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Amvis Holdings.Inc. Corporate Events

Amvis Holdings Announces Improvement Measures Following Investigation

Amvis Holdings, Inc. has announced a series of improvement measures following an investigation into its operations, prompted by media reports of potential improper medical fee claims. The investigation found no organizational misconduct but highlighted areas needing improvement. In response, Amvis is implementing measures to define and standardize home-visit nursing services, enhance recruitment and staffing systems, rebuild internal controls, and improve internal communication. These initiatives aim to strengthen the company’s operational efficiency and compliance, ultimately benefiting stakeholders by ensuring accurate service delivery and robust internal processes.

Amvis Holdings Completes Semi-Annual Report Submission

Amvis Holdings, Inc. has announced the completion of its semi-annual report submission for the fiscal year ending September 30, 2025, following an approved extension. The company expressed apologies for any inconvenience caused by the delay, emphasizing its commitment to maintaining transparency and accountability with its stakeholders.

Amvis Holdings Delays Third Quarter Financial Results Disclosure

Amvis Holdings, Inc. announced a delay in the disclosure of its financial results for the third quarter of the fiscal year ending September 30, 2025. The delay, expected to exceed 45 days post-quarter, is due to the time required to complete procedures related to the financial results. This postponement may cause inconvenience and concern among stakeholders, but the company assures that the specific date for the announcement will be disclosed promptly once determined.

Amvis Holdings Reports Profit Decline Amid Sales Growth

Amvis Holdings, Inc. reported a decline in profits for the first six months of the fiscal year ending September 30, 2025, despite an increase in net sales. The company’s operating profit and profit attributable to owners of the parent decreased significantly compared to the previous year, indicating challenges in maintaining profitability. The company also announced the inclusion of a new subsidiary, Midori, in its consolidated financial statements, reflecting strategic expansion efforts.

Amvis Holdings Receives Investigation Report on Billing Allegations

Amvis Holdings, Inc. has received an investigation report from a Special Investigation Committee, which was formed to examine allegations of improper billing of medical fees. The investigation found no evidence of systematic misconduct, and the financial impact is minor, amounting to approximately ¥63 million. The company acknowledges deficiencies in its internal systems and is committed to improvements, including organizational restructuring and enhanced recordkeeping. The findings have caused concern among stakeholders, and Amvis plans to disclose further initiatives at its upcoming earnings announcement.